SOPHIA ANTIPOLIS, France – April 28, 2020 | According to Optofluidic Bioassay, COVID-19 antibody testing which is portable, fast, cheap and highly precise could be possible with a microfluidic device invented by the company. Optofluidic Bioassay was founded in 2015 as a spin-off of the University of Michigan. The company was identified as relevant microfluidics[…]
SOPHIA ANTIPOLIS, France – June 14, 2019: Abcellera’s patent involved in its collaboration with Gilead in infectious disease. AbCellera has announced a partnership with Gilead to discover antibodies for infectious disease. AbCellera will apply its expertise in single-cell screening of natural immune sources to generate rich panels of antibody candidates for evaluation by Gilead. Gilead[…]
SOPHIA ANTIPOLIS, France – May 6, 2019: Nanopore sequencing is one of the next-generation sequencing (NGS) technologies believed to be capable of revolutionizing DNA analysis. Nanopore sequencing is performed using an electrical detection method, which generally includes transporting a sample through the nanopore, which is immersed in a conducting fluid, and applying electric potential across[…]
“Microfluidic technologies have been around for a while, but only in the last few years have certain applications started benefiting from microfluidic breakthroughs”, comments Technology & Market Analyst, Sébastien Clerc from Yole Développement (Yole), part of Yole Group of Companies (1). Indeed, microfluidic technologies have finally found sweet spots and there are already credible options for[…]